Hemp Feed Coalition Submits The First Ingredient Application In The United States For Hemp To Be Federally Approved As A Feed Ingredient For Poultry

COLORADO:  The Hemp Feed Coalition (HFC) is proud to announce the first submission for hemp to become an approved animal feed ingredient has been put forward for consideration by the Association of American Feed Control Officials and the U.S. Food and Drug Association-Center for Veterinary Medicine (FDA-CVM). Once approved, this ingredient application will allow hempseed meal and cake to be legally used as commercial feed for laying hens.  Led by Coalition leadership, hemp and feed industry experts, and researchers; the submission is a culmination of a two-year long effort, consisting of an ingredient investigation of hemp seedcake and meal and a clinical trial to demonstrate the safety and efficacy of hemp for laying hens.

“The first one is always the hardest; and it was definitely a group effort to submit the first ever application in the US for hemp as an official feed ingredient,” Hunter Buffington, Executive Director of the HFC, said of the first submission. To meet the FDA-CVM rigorous standards of safety and efficacy, the hemp industry shared Certificates of Analysis from across the United States to demonstrate hempseed cake and meal can be consistently grown and processed. This effort was combined with expertise from hemp and feed industry leaders, research from our principal investigators and the support of our Project Champion-IND HEMP to bring the submission to the FDA-CVM for scientific review.

“The coalition has worked hard over the last two years and we are finally getting our first steps behind us in the world of federal approval; something that most every day Americans would be shocked to know is so heavily regulated. HFC doesn’t just represent the hemp industry but all the farmers and ranchers out there that deserve the opportunity to monetize their efforts and compete on the global market of industrial hemp.”  – Morgan Elliott, Co-Founder of IND HEMP.

Now that the first application has been submitted, the HFC will turn its focus to research on other hemp by-products: oil, sediment, hulls, pulp and screenings to investigate their benefit and safety as feed ingredients. In addition, this work will include the clinical trials necessary to add ruminates to the hempseed meal application that was submitted. “Opening new markets is our secondary mission,” said Buffington “Commoditizing safe and healthy by-products from hemp processing will provide farmer and processor revenue and a build a steady supply as the industry matures in the next few years.” The HFC will be leading those efforts by bringing researchers, hemp and feed industry experts and coalition advisors together for additional applications and Federal regulatory approval for new hemp ingredients as feed for animals.

The Hemp Feed Coalition (HFC) began in 2018 as a pilot project under the Colorado Hemp Industries Association (COHIA) before forming its own non-profit organization in 2020. The HFC intends to continue its mission to gain federal approval for additional hemp by-products as commercial animal feed. To support the work of the HFC, visit our website and become a member. Members receive discounts, special offers, invitations and member only communications. For more information on current research and ingredient data collection contact Hunter Buffington at hunter@hempfeedcoalition.org

Charlotte’s Web Secures U.S. Utility Patents For Two New Hemp Varietals With Superior Cannabinoid Expression

COLORADO:  Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market leader in hemp CBD wellness products, announces that Charlotte’s Web, Inc., a wholly-owned subsidiary, has been granted U.S. Utility Patents for its hemp genetics by the United States Patent and Trademark Office. The newly issued patents cover two of the Company’s new feminized seed hybrid hemp varieties developed under the Company’s breeding program; ‘Kirsche’ (US Patent No. 10,888,060) and ‘Lindorea’ (US Patent No. 10,888,059).  ‘Lindorea’ and ‘Kirsche’ are the world’s first two allowed U.S. Utility Patents reading on feminized hybrid hemp plants.

TSX:CWEB - Charlotte's Web is the market leader in hemp CBD extract products and is a Certified B Corp publicly traded company with five patent awards.. (CNW Group/Charlotte's Web Holdings, Inc.)

The Company now has earned a total of five U.S. hemp variety patent grants: one Plant Patent and four Utility Patents as it advances the science of hemp horticulture.

“Achieving the first patented hemp hybrids demonstrates that it is possible to improve hemp through similar methods as other agronomic crops using natural breeding techniques.  We believe that ‘Kirsche’ and ‘Lindorea’ are some of the hardiest botanical hemp varietals under cultivation.” said Bear Reel, Charlotte’s Web vice president of cultivation and R&D and the developer of the new varietals.

‘Kirsche,’ having a naturally rich phytochemical profile and good disease resistance, has an excellent plant structure and a flower-to-stem ratio that is compatible with mechanical harvesting innovations. ‘Lindorea,’ developed for the Kentucky climate, exhibits broad resistance to fungal pathogens in the North and South Appalachian regions but also in the wetter autumn climate in Ore. while delivering record breaking yields.

“The ‘Kirsche’ and ‘Lindorea’ U.S. patents represent more than four years of scientific research and trials, and some of the most cutting-edge work being conducted in genetics in the hemp CBD industry today,” said Deanie Elsner, Charlotte’s Web president and CEO. “Charlotte’s Web will continue to advance and protect our prized hemp varietals to build consumer confidence in the consistency of our hemp extract products. This is at the heart of our mission to advance the science of hemp for the greater benefit of the people who choose these products for their wellness needs.”

Pre-Christmas Cannabis Sales Expected To Hit $400 Million, New Years Sales To Top $81 Million

COLORADO:  Business intelligence from Akerna, an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning software technology, estimates cannabis sales to spike this holiday season.

“To determine how the Christmas and New Year’s holidays would affect cannabis sales nationally, we took a look at last year to see how sales have been influenced by these holidays,” explains James Ahrendt. “For example, the Friday before Christmas was the second largest single sales day of 2019, while the 7-day period leading up to Christmas was 15% higher grossing than the weekly average of 2019.”

Farmer Tom Lauerman in festive garb

Akerna anticipates that in the week leading up to the start of the Christmas holiday (12/18-12/24), weekly average cannabis sales will increase 15%, generating $400 million.

The Friday preceding Christmas (12/18) will most likely be the largest sales day of the month, experiencing a 74% surge in sales. New Year’s Eve is expected to experience a 68% increase in sales, generating $81 million. The average order total is predicted to be $7 higher than the 2020 average, with adult-consumers spending $79 and medical patients spending $121.

Additional Holiday Season Predictions

Sales by product type:

  • Flower – 45%
  • Cartridge/Pens – 31%
  • Concentrates – 13%
  • Infused Edibles – 9%
  • Other – 2%

Sales by gender

  • Male – 64%
  • Female – 36%

Sales by age

  • Under 30 – 28%
  • 30-40 –30%
  • 40-50 – 19%
  • 50-60 –13%
  • Over 60 – 10%

How Big Is Legal Cannabis In Colorado?

MED Resources and Statistics

As of December 1, 2020

Medical Marijuana Business License Numbers:

  • 663 Cultivations
  • 6 Delivery (Permits)
  • 7 Operators
  • 216 Product Manufacturers
  • 1 Development and Research Cultivation
  • 431 Stores
  • 11 Testing Facilities
  • 6 Transporters

 Retail Marijuana Businesses License Numbers:

  • 712 Cultivations
  • 3 Hospitality
  • 9 Operators
  • 288 Product Manufacturers
  • 604 Stores
  • 12 Testing Facilities
  • 12 Transporters

Individual Licensees:

  • 185 Owner Entities
  • 1,726 Business Owners (Natural Person)
  • 39,653 Employee Licensees

MED Licensee Demographic Data

Geocann Appoints Michael Davidson, M.D. Head of Innovation, Technology and Clinical Research

COLORADO:  Geocann announced that Michael Davidson, M.D., has joined the company’s executive management team as Head of Innovation, Technology, and Clinical Research where he will focus on cutting-edge health solutions proven through well-designed clinical studies. Davidson is an internationally recognized expert on statins, novel lipid-lowering drugs, and omega-3 essential fatty acids. He has coordinated more than 1,000 clinical trials and published more than 250 articles for leading medical journals.

“Geocann’s initial cannabis research has set the benchmark for what’s demanded in an ever-evolving industry with implications and opportunities in a wide range of product applications such as nutritionals, pharmaceuticals, cosmeceuticals, and medical devices,” Davidson said. “I’m honored to lead our efforts in new research with a vision to make a significant impact that adds value to Geocann, our global brand partners, and the industry as a whole.”

Davidson is well-recognized in both the medical and financial communities for his successful business acumen. He founded the Chicago Center for Clinical Research (now owned by Radiant Research Inc.), which became the largest investigator site in the United States under Davidson’s leadership. He was the co-founder and Chief Medical Officer of Omthera Pharmaceuticals, which was acquired by Astra Zeneca Pharmaceutical in 2013 for $443 million USD. Most recently, he founded Corvidia Therapeutics in 2014 where he also served as the Chief Scientific Officer prior to it being acquired for $2.1 billion USD by Novo Nordisk in June 2020.

“Dr. Davidson’s experience and leadership will help guide our research and clinical study success that address the unmet needs of the hemp and cannabis industry,” Jesse Lopez, CEO and founder of Geocann, said. “Our goal is to provide innovative product solutions that are differentiated by patented drug delivery system technology and validated with first-to-market scientific evidence. While new cannabis markets are opening in the U.S., Canada, South America, Europe, and Australia, among others, we are keenly focused on expanding the depth of supporting science to increase our value proposition and protect our market leadership position in innovation and novel product solutions.”

According to Lopez, the company created the position to provide medical leadership in a business sector that is still in its infancy. “Davidson will offer invaluable experience in clinical study design, the review of scientific manuscripts and publications, and maintaining a laser focus on introducing the newest cannabis breakthroughs and how they relate to conditions such as pain, sleep, opioid-reduction, anxiety, and much more,” Lopez stated.

Geocann has been well-recognized for its substantial investments in research in order to meet the evolving demands of the marketplace and offer significant product differentiation to leading lifestyle and medical brands around the world. In addition to recent pharmacokinetic studies (Molecules 2019, 24(16), 2967) and the stability data for its products, further investments in new clinical research focused on both pharmacokinetic performance and clinical endpoints are well under way. Additionally, multiple toxicology studies have been completed and will be published this year as part of the company’s FDA GRAS (Generally Regarded As Safe) Notification and Novel Food application.

 

Colorado Gov. Polis Grants Historic Pardons For Marijuana Convictions

COLORADO:Governor Jared Polis today signed an Executive Order granting pardons to those who have been convicted of possessing one ounce or less of marijuana. In June, Gov. Polis signed the bipartisan H.B. 20-1424, sponsored by Rep. James Coleman, Sen. Julie Gonzales and Sen. Vicki Marble, including an amendment sponsored by Sen. Gonzales, which authorizes the Governor to grant pardons to a class of defendants who were convicted of the possession of up to two ounces of marijuana. Reps. Leslie Herod and Jonathan Singer were also champions of passing this legislation. The new law went into effect this month.

“We are finally cleaning up some of the inequities of the past by pardoning 2,732 convictions for Coloradans who simply had an ounce of marijuana or less. It’s ridiculous how being written up for smoking a joint in the 1970’s has followed some Coloradans throughout their lives and gotten in the way of their success,” said Governor Jared Polis. “Too many Coloradans have been followed their entire lives by a conviction for something that is no longer a crime, and these convictions have impacted their job status, housing, and countless other areas of their lives. Today we are taking this step toward creating a more just system and breaking down barriers to help transform people’s lives as well as coming to terms with one aspect of the past, failed policy of marijuana prohibition.”

This pardon applies to state-level convictions of possession for one ounce or less of marijuana, as identified by the Colorado Bureau of Investigation (CBI).  Under H.B. 20-1424, the Governor is granting pardons for a class of people with convictions for possession of one ounce or less of marijuana. The individuals who have these convictions did not need to apply for pardons, and the Governor’s Office has not conducted individual assessments of the people who have been pardoned through this process. Individuals convicted of municipal marijuana crimes, or individuals arrested or issued a summons without a conviction, are not included in the pardons.

Individuals who are unsure whether a conviction on their record has been pardoned may fill out a form to request confirmation of a pardon on the Colorado Bureau of Investigations website. To obtain their entire criminal history, people can visit CBIRecordsCheck.com. Once a conviction is pardoned, it will not appear on a criminal history obtained on the records check website.

For further questions visit the FAQ document.

Visit COMarijuanaPardons.com for more information.

Botanacor Offers A New “Dry Weight Potency (USDA)” Test

Botanacor Offers a New “Dry Weight Potency (USDA)” Test to Allow Hemp Producers to Achieve USDA Regulatory Compliance

USDA Will Soon Require Hemp Producers to Test Crops for Total THC Calculated on a Dry Weight Basis  

COLORADO: Botanacor Laboratories, the widely recognized leader in accredited testing of hemp biomass and hemp-derived CBD products, today announced that it offers a new test to hemp producers. Responding to new USDA regulations that will soon apply to U.S. states, territories, and tribes, Botanacor can now test hemp biomass for total THC calculated on a dry weight basis.

Offering the industry’s fastest turnaround times for its “moisture corrected” test results, Botanacor provides customers a Certificate of Analysis that includes Measurement Uncertainly for 15 cannabinoids.  Botanacor calculates the total THC using HPLC and accurately accounts for moisture content using the Karl Fischer Method for advanced titration.

Botanacor’s new test for total THC calculated on a dry weight basis recognizes that THC content is expressed as a percent of biomass weight.  However, moisture can add weight and distort the THC content calculation, with implications for product safety, consistency, potency, and regulatory compliance.  Only total THC calculated on a dry weight basis provides an accurate THC content across any type of hemp sample submitted for testing, no matter the initial moisture content of the samples submitted to Botanacor. (For background, link to the USDA Interim Final Rule.)

“Botanacor is known nationally for rapidly developing the validated tests required for our hemp-producing customers’ regulatory compliance,” said Mike Branvold, President of Botanacor.  “This new Dry Weight Potency (USDA) test is another example of Botanacor standing up a test in anticipation of USDA regulation to give our customers a competitive edge.”

Colorado Senator Gardner Calls On USDA To Protect Hemp Industry

DISTRICT OF COLUMBIA: U.S. Senator Cory Gardner (R-CO) is calling on the U.S. Department of Agriculture (USDA) to delay implementation of the U.S. Domestic Hemp Production Program Interim Final Rule (IFR), which, as currently drafted, threatens the industrial hemp industry’s potential for Colorado’s farmers and seriously undermines this growing industry.

“The United States is now poised to transition from being a world-leading hemp importer to a world-leading hemp producer, and many look to Colorado farmers for guidance and clarity for the industry because Colorado is home to one of the longest-running state hemp programs,” wrote Senator Gardner. “I have worked with my colleagues and state officials to share with the USDA Colorado’s hemp experience, encourage greater flexibility for farmers, and encourage innovation of the industry. This includes echoing comments submitted by the State of Colorado during the IFR comment period.”

“I appreciate your leadership to the nation’s farmers throughout this extraordinary challenging time. Given these challenges, it is hard to overlook the great promise that the industrial hemp industry could provide to farmers if regulation is done in the proper manner. I encourage you to delay the final implementation of the IFR and work directly with state regulators and the industry to ensure workable rules that allow the industry to thrive,” Gardner concluded.

The full text of the letter can be found here and below:

Dear Secretary Perdue:

I write regarding the United States Department of Agriculture’s (USDA) U.S. Domestic Hemp Production Program Interim Final Rule (IFR), which, as currently drafted, threatens the industrial hemp industry’s potential for Colorado’s farmers and seriously undermines this burgeoning industry. I join the growing chorus of my colleagues, the National Association of State Departments of Agriculture, and the National Industrial Hemp Council in requesting that you use your secretarial discretion to delay implementation of the final rule in order to address several outstanding issues.

The nation’s hemp industry was given an enormous boost when hemp was de-scheduled in the Agriculture Improvement Act of 2018. The United States is now poised to transition from being a world-leading hemp importer to a world-leading hemp producer, and many look to Colorado farmers for guidance and clarity for the industry because Colorado is home to one of the longest-running state hemp programs. Since 2014, Colorado’s program has grown to include about 2,600 active registrations. In 2019, there were nearly 90,000 acres of registered hemp production in the state. Colorado farmers have been at the forefront of the hemp industry, driving change and innovation across the country. The state carefully balances regulatory oversight and economic support, allowing it to have a thriving industry and be a leader to other states.

I have worked with my colleagues and state officials to share with the USDA Colorado’s hemp experience, encourage greater flexibility for farmers, and encourage innovation of the industry. This includes echoing comments submitted by the State of Colorado during the IFR comment period. Despite my communications, there remain serious concerns about how the IFR will impact the Colorado industry.

I appreciate your leadership to the nation’s farmers throughout this extraordinary challenging time. Given these challenges, it is hard to overlook the great promise that the industrial hemp industry could provide to farmers if regulation is done in the proper manner. I encourage you to delay the final implementation of the IFR and work directly with state regulators and the industry to ensure workable rules that allow the industry to thrive.

Helix Technologies Launches Nation’s First Online MMJ Reciprocity Platform In New Mexico

COLORADO:  Helix Technologies, announced today that New Mexico’s online medical marijuana reciprocity portal is live and has been serving out of state patients living or vacationing in New Mexico for almost a month as of this writing.

The system, which is the first of its kind for US medical cannabis programs, allows state regulators to electronically register and track out of state patients into the patient registry. The system decreases time and costs associated with paper only patient registries and allows the state to track and enforce dispensing limits in real time to prevent potential diversion to the black market.

The new platform benefits all stakeholders in the New Mexico industry as it allows out of state patients a convenient way to access medical cannabis while enjoying the many outdoor and cultural opportunities in New Mexico. Since going live with the reciprocity module on July 1st, more than 1,700 out of state patients have been registered for the program. “We’re encouraged by the ability of this platform to assure people visiting New Mexico get the medicine they need when cannabis has been recommended as a treatment by their medical provider at home,” said New Mexico Department of Health Medical Cannabis Program Director Dr. Dominick Zurlo. “We appreciate the efforts of Helix Biotrack to work with us toward the goal of assuring visiting patients experience uninterrupted treatment and relief for their medical conditions.”

“We are always looking for ways to work with our Government partners to improve transparency, ease of use, and ultimately public safety,” said Helix Biotrack COO Dr. Moe Afaneh. “This is the first step towards digitally bridging states’ medical markets, while ultimately improving access for patients looking to explore New Mexico, bringing in new patients for the industry, and saving everyone time and money in the process. We’re very proud to bring another industry-first innovation to Seed to Sale Tracking, with more to come.”

Colorado Ag Department Provides State Hemp Plan Status Update

COLORADO:  The U.S. Department of Agriculture (USDA) has requested Colorado clarify and revise certain elements of its State Hemp Management Plan, submitted on June 18, 2020. The Colorado Department of Agriculture (CDA) is currently reviewing USDA’s comments and questions and considering revisions as it continues to prioritize representing the needs of the state’s industrial hemp registrants and stakeholders.

“As we have done from day one, CDA is working through the state plan submission and approval process in a careful and comprehensive manner to best serve the needs of Colorado,” said Colorado Commissioner of Agriculture Kate Greenberg. “Given the many changes at the federal level, we are working hard to create a stable and sound regulatory environment so that Colorado’s hemp industry can continue to lead the nation.”
Feedback received from numerous stakeholders statewide and over several months contributed to the plan, including input from farmers, processors and product manufacturers, state and local government agencies, healthcare professionals, financial services providers, law enforcement, and academic institutions, as well as consultation with Southern Ute and Ute Mountain Ute tribes, as part of CDA’s Colorado Hemp Advancement and Management Plan.